Following a hearing in mid-October that saw Missouri Division of Cannabis Regulation leadership questioned by a bi-partisan rules committee, the Joint Committee on Administrative Rules (JCAR) has ...

Each month Patients asks a handful of the best dispensary representatives from around the state to give a recommendation for their favorite, or the most popular, product at their dispensary.

Missouri cannabis industry leaders gathered in Kansas City this weekend as Greenway hosted the annual Best of the Industry Awards at Warehouse on Broadway, recognizing standout businesses and ...

The legal cannabis market has witnessed a surge in recent years, driven by increasing global acceptance and legalization. However, like other agricultural sectors, it faces significant challenges, ...

The rapidly evolving cannabis industry is accompanied by an equally dynamic lexicon, where terms like “cultivar” and “strain” are often used interchangeably. However, a deeper understanding of these ...

Representative Chad Perkins, R-Bowling Green, and Senator Nick Schroer, R-St. Charles, have taken steps to address the regulation of intoxicating cannabinoids in Missouri, pre-filing House Bill 1781 ...

The Missouri Department of Health and Senior Services Division of Cannabis Regulation released its 2025 Chief Equity Officer Activity Report, detailing enforcement actions, operational progress, and ...

Article XIV § 2.4(1)(G)B allows for the provision of licenses intended to facilitate scientific research or education. In accordance with this authority, the Division of Cannabis Regulation (DCR) is ...

Michigan-based retailer launches limited-time initiative to support those affected by recent airline closure In response to the sudden shutdown of Spirit Airlines, JARS Cannabis and All-Star Brands ...

President Donald Trump is signaling a potential shift in federal marijuana policy as his administration considers directing federal agencies to reclassify cannabis under the Controlled Substances Act, ...

Missouri marijuana sales remain ahead of last year’s pace through the first half of 2026, with the state reporting $770.86 million in combined retail sales through June. As of the end of the month, ...

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...